Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Therapeutics, Inc."
Count: 2846
Selected: 0
NCT IDTitle
NCT04221230Study in Major Depressive Disorder With BTRX-335140 (NMRA-335140) vs Placebo
NCT00429936Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration
NCT05363449Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis
NCT03897257A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis
NCT05753189Phase 3 Safety Study for the Treatment of Presbyopia Subjects
NCT04080206A Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque Psoriasis
NCT05728944Phase 3 Efficacy Study of LNZ101 for the Treatment of Presbyopia
NCT05656027Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia
NCT05936489Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia
NCT04243486A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp Psoriasis
NCT03759197A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis
NCT03731052Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)
NCT05294328Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia
NCT03307577A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris
NCT05776069Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease
NCT04205227ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors
NCT06161571A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
NCT06215716A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NCT05954988A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients
NCT02368210A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306)
NCT02742441A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310)
NCT02367911A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis
NCT01700985A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis
NCT01698333Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression
NCT04740476An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome
NCT04442295An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome
NCT06253871A Phase 1/1b Study of IAM1363 in HER2 Cancers
NCT06326411A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
NCT06171750Phase I Study of ANK-101 in Advanced Tumors
NCT04665206Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors Enriched for Tumors With NF2 Gene Mutations
NCT03065556A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203)
NCT04159831A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions
NCT04485013TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
NCT05039450A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)
NCT06253923Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301) in Patients With Severe Traumatic Brain Injury (TBI).
NCT04767529A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)
NCT05725018EB-101 Treatment for New and Previously Treated Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
NCT05971329Pilot Study of ZetaFuse™ Bone Graft for the Treatment of Cervical Degenerative Disc Disease
NCT01263379Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa
NCT05662397A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody
NCT03201562A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
NCT05866419Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
NCT04645797A Dose Escalation Study of APR003 in Patients With Advanced Colorectal Cancer (CRC) With Malignant Liver Lesions
NCT05947578The Safety and Tolerability of CLZ-2002 in Patients With Charcot-Marie Tooth Disease.
NCT05280067ZetaFuse™ Bone Graft in the Repair of Bone Defects From Metastatic Breast Cancer in the Spinal Vertebral Body
NCT06087653Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)
NCT05392751Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosa
NCT05651022DECOY20 Study in Patients With Advanced Solid Tumors
NCT05814107Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus
NCT05917470A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.